Increased prevalence of allergic asthma from 1996 to 2006 and further to 2016-results from three population surveys
- PMID: 28608416
- DOI: 10.1111/cea.12963
Increased prevalence of allergic asthma from 1996 to 2006 and further to 2016-results from three population surveys
Abstract
Background: During the latter half of the 20th century, the prevalence of asthma and many other allergic diseases has increased. Information on asthma prevalence trends among adults after 2010, especially regarding studies separating allergic asthma from non-allergic asthma, is lacking.
Objective: The aim was to estimate prevalence trends of current asthma among adults, both allergic and non-allergic, from 1996 to 2016.
Methods: Three cross-sectional samples from the same area of Sweden, 20-69 years, participated in surveys with the same questionnaire in 1996 (n=7104 participants, 85% response rate), 2006 (n=6165, 77%) and 2016 (n=5466, 53%), respectively. Allergic rhino-conjunctivitis (ARC) was used as a marker for allergic sensitization to define allergic asthma.
Results: The prevalence of current asthma increased from 8.4% (95% CI: 7.8-9.0) in 1996 to 9.9% (95% CI: 9.2-10.6) in 2006 and 10.9% (95% CI: 10.1-11.7) in 2016 (P<.001). Allergic asthma increased from 5.0% (95% CI: 4.5-5.5) in 1996 to 6.0% (95% CI: 5.4-6.6) in 2006 and further to 7.3% (95% CI: 6.6-8.0) in 2016 (P<.001), while the prevalence of non-allergic asthma remained stable around 3.4%-3.8%. The increase in current asthma was most pronounced among women and among the middle-aged. Physician-diagnosed asthma, asthma medication use and ARC also increased significantly, while the prevalence of symptoms common in asthma such as wheeze and attacks of shortness of breath decreased slightly or was stable. The prevalence of current smoking decreased from 27.4% in 1996 to 12.3% in 2016.
Conclusions and clinical relevance: The prevalence of allergic asthma increased from 1996 to 2006 and further to 2016, while the prevalence of non-allergic asthma remained on a stable prevalence level. The prevalence of symptoms common in asthma decreased slightly or was stable despite a substantial decrease in the prevalence of current smoking. Clinicians should be aware that the previously observed increase in prevalence of allergic asthma is still ongoing.
Keywords: asthma; epidemiology; rhinitis.
© 2017 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd.
Similar articles
-
Changes in the prevalence of asthma and respiratory symptoms in western Sweden between 2008 and 2016.Allergy. 2019 Sep;74(9):1703-1715. doi: 10.1111/all.13840. Epub 2019 Jul 1. Allergy. 2019. PMID: 31021427
-
The association between asthma and rhinitis is stable over time despite diverging trends in prevalence.Respir Med. 2015 Mar;109(3):312-9. doi: 10.1016/j.rmed.2015.01.002. Epub 2015 Jan 21. Respir Med. 2015. PMID: 25638411
-
Time trends in asthma and wheeze in Swedish children 1996-2006: prevalence and risk factors by sex.Allergy. 2010 Jan;65(1):48-55. doi: 10.1111/j.1398-9995.2009.02105.x. Epub 2009 Oct 1. Allergy. 2010. PMID: 19796226
-
Epidemiology of rhinitis and asthma.Clin Exp Allergy. 1998 Jun;28 Suppl 2:3-10. Clin Exp Allergy. 1998. PMID: 9678821 Review.
-
Changing prevalence of allergic rhinitis and asthma.Ann Allergy Asthma Immunol. 1999 Mar;82(3):233-48; quiz 248-52. doi: 10.1016/S1081-1206(10)62603-8. Ann Allergy Asthma Immunol. 1999. PMID: 10094214 Review.
Cited by
-
Early-life risk factors for development of asthma from 8 to 28 years of age: a prospective cohort study.ERJ Open Res. 2022 Dec 12;8(4):00074-2022. doi: 10.1183/23120541.00074-2022. eCollection 2022 Oct. ERJ Open Res. 2022. PMID: 36655222 Free PMC article.
-
Role of allergen immunotherapy and biologics in allergic diseases.Curr Opin Immunol. 2024 Dec;91:102494. doi: 10.1016/j.coi.2024.102494. Epub 2024 Oct 1. Curr Opin Immunol. 2024. PMID: 39357079 Review.
-
All-cause and cause-specific mortality in respiratory symptom clusters: a population-based multicohort study.Respir Res. 2025 Apr 16;26(1):150. doi: 10.1186/s12931-025-03224-7. Respir Res. 2025. PMID: 40241067 Free PMC article.
-
Harnessing the Farm Effect: Microbial Products for the Treatment and Prevention of Asthma Throughout Life.Immunol Rev. 2025 Mar;330(1):e70012. doi: 10.1111/imr.70012. Immunol Rev. 2025. PMID: 40035333 Free PMC article. Review.
-
The therapeutic potential of glucagon-like peptide-1 receptor analogs for neuroinflammation in the setting of asthma.Explor Asthma Allergy. 2025;3:100967. doi: 10.37349/eaa.2025.100967. Epub 2024 Dec 17. Explor Asthma Allergy. 2025. PMID: 40474934 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical